Anna Rivkin insider trades

Open-market stock purchases and sales by Anna Rivkin, Chief Business Officer at Foghorn Therapeutics Inc, from SEC Form 4 filings since Sep 3, 2024.

Recent trades

DateStockTradeValue
Jan 30, 2026FHTX Foghorn Therapeutics IncBought (not open market)$942K

Companies traded

  • FHTX Foghorn Therapeutics Inc: other filings, last Jan 30, 2026

Get free alerts when Anna Rivkin files a new trade →